Finasteride Tablet, Film Coated
Product Images NDC 68788-8433

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 68788-8433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Finasteride Figure 1 (Finasteride Fig.1.jpg)

A line graph depicting mean change from baseline ± 1 standard error over four years for Finasteride 5 mg tablets compared to placebo. The x-axis shows time points from baseline to Year 4; the y-axis shows mean change values. Two lines represent Finasteride and placebo groups, with corresponding sample sizes noted below each time point.*

FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2.jpg)

A line graph depicting the percent of patients over observation time (months) comparing Finasteride and placebo groups. The graph shows cumulative number of events and numbers at risk per year for each group at multiple time points up to 48 months. Finasteride group exhibits a lower event rate compared to placebo over time.*

FDA Label Image

Finasteride Figure 2 (Finasteride Fig.3.jpg)

A line graph depicting mean percent change from baseline plus or minus one standard error over four years. The x-axis shows the timeline from baseline to year 4, and the y-axis shows mean percent change from -20 to 20. Two groups are compared: Placebo (circles) showing a positive increase over time and Finasteride (squares) showing a negative change. Sample sizes for each group at each time point are listed below the x-axis.*

FDA Label Image

Finasteride Figure 4 (Finasteride Fig.4.jpg)

A line graph depicting the percent of participants with an event over years from randomization for four groups: Placebo, Finasteride, Doxazosin, and Combination. The y-axis shows percent with event (0-25%), and the x-axis shows years from randomization (0-5.5 years). Placebo group has the highest event rate, followed by Finasteride, Doxazosin, and Combination with the lowest.*

FDA Label Image

Structutre (Finasteride Structure)

Chemical structure diagram of finasteride, showing its steroidal backbone with multiple rings, methyl groups, and carbonyl functional groups, consistent with the labeled active ingredient finasteride.*

FDA Label Image

Finasteride-fig.3_ (Fig 3finasteride)

A line graph depicting the cumulative percent of patients over 48 months for two groups: Finasteride and Placebo. The x-axis shows observation time in months, and the y-axis shows percent of patients, ranging from 0% to 15%. The graph includes a table reporting the number of events and patients at risk per year for both groups.*

FDA Label Image

Finasteride Tablets Usp 5mg (Finasteride 5mg 30tab)

Finasteride Tablets, USP 5 mg film-coated tablet packaging label manufactured by Preferred Pharmaceuticals, Inc. The label states the product is generic for Proscar and includes storage instructions, a caution about misuse, and manufacturer details as Ascend Laboratories, LLC. It has space for lot, batch, expiration date, and quantity details. Directions are provided in English and Spanish on a yellow background area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.